Voriconazole-induced periostitis post lung transplantation
- PMID: 35309380
- PMCID: PMC8924534
- DOI: 10.1016/j.radcr.2022.01.078
Voriconazole-induced periostitis post lung transplantation
Abstract
Voriconazole is a broad-spectrum triazole antifungal used to treat invasive fungal infections. It is commonly used prophylactically in immunocompromized patient cohorts, including transplant recipients. Diffuse periostitis is a very rare complication of chronic voriconazole use. It is associated with diffuse bone pain, elevated serum alkaline phosphatase and fluorine levels. Characteristic imaging findings include periosteal thickening with a dense, nodular, irregular and often bilateral pattern. We describe the case of a 71-year-old female who presented with multifocal bone pain six years following double lung transplantation. Her post transplantation course had been complicated by a life threatening episode of sepsis secondary to Scedosporium apiospermum, a rare invasive fungal infection following which lifelong prophylaxis with oral Voriconazole was commenced. We discuss the characteristic clinical and imaging manifestations of this rare condition.
Keywords: Lung transplantation; Periostitis; Voriconazole.
© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures



References
-
- Barajas M., McCullough K., Merten J., Dierkhising R., Bartoo G., Hashmi S., et al. Correlation of pain and fluoride concentration in allogeneic hematopoietic stem cell transplant recipients on voriconazole. Biol Blood Marrow Transpl. 2016;22(3):579–583. doi: 10.1016/j.bbmt.2015.10.021. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources